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Objective
The STET trial is a two-centre open RCT comparing
morbidity and healthcare resource use when off-pump
coronary artery bypass surgery is carried out via a left
anterolateral thoracotomy incision (ThoraCAB) or via a
conventional median sternotomy incision (OPCAB). It
was hypothesised that post-operative recovery would be
faster with ThoraCAB.
Methods
Post-operative hospital stay is a commonly used mea-
sure of recovery. However, in an open surgical trial,
where the decision to discharge the patient from hospi-
tal lies with the surgeon, post operative hospital stay is
susceptible to bias. For the STET trial we developed an
objective measure of recovery. Recovery time was
defined as the time from surgery until the patient was
considered fit for discharge. Patients were classified fit
(a) when the x-ray was clear (no evidence of pleural
effusion requiring drainage, lung collapse/consolidation,
pneumothorax); (b) there was no suspected systemic,
lower respiratory tract or wound infection; (c) routine
blood results and temperature were normal and (d)
when physically mobile (walking 70m, bowels open and
oxygen saturation>95%). These recovery criteria were
monitored daily until discharge.
Results
184 patients were recruited (91 randomised to Thora-
CAB, 93 to OPCAB). In the OPCAB group 77% were
classified fit at or before discharge versus 68% in the
ThoraCAB group. For the remainder, the recovery time
was censored because discharge occurred before all the
criteria were met. Insufficient mobility accounted for the
majority of censored observations. The median recovery
time was 6 days, IQR [4,7] in the ThoraCAB group ver-
sus 5 days, IQR [4,7] in the OPCAB group (Time ratio
(ThoraCAB/OPCAB) 1.03 (95%CI [0.94, 1.14], p=0.53).
In contrast, the median time to discharge was 5 days in
the ThoraCAB group versus 6 days in the OPCAB
group.
Conclusion
The anticipated faster recovery with ThoraCAB was not
found and a significant proportion of patients were dis-
charged before all the recovery criteria were met. The
results from the STET trial illustrate the bias associated
with clinical decision making in an open RCT. The mea-
sure of recovery time (with slightly modified criteria) is
being used in other cardiac surgery trials.
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